JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, X.
Right arrow Articles by Kowey, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, X.
Right arrow Articles by Kowey, P. R.

Vol. 292, Issue 1, 196-200, January 2000

Effects of Captopril Treatment of Renovascular Hypertension on beta -Adrenergic Modulation of L-Type Ca2+ Current1

Xiaoping Xu, Seth J. Rials2, Ying Wu, Tengxian Liu, Roger A. Marinchak and Peter R. Kowey

Cardiovascular Division, The Lankenau Hospital and Medical Research Center, Wynnewood, Pennsylvania

beta -Adrenergic stimulation of cardiac L-type Ca2+ channels is severely impaired in hypertrophied and failing hearts of both experimental animals and humans. The aim of this study was to test the hypothesis that chronic treatment of renovascular hypertension with captopril restores normal beta -adrenergic responsiveness of L-type Ca2+ channels in cardiac myocytes. Left ventricular hypertrophy was induced in rabbits by unilateral renal artery banding and contralateral nephrectomy. Beginning at 3 months after banding, hypertensive rabbits were treated with captopril for 3 months. The responsiveness of L-type Ca2+ current (ICa,L) to (±)-isoproterenol was investigated with the whole-cell patch-clamp technique. (±)-Isoproterenol (1 µM) induced an increase of ICa,L at 0 mV of 126 ± 20% (n = 13) in control myocytes versus 69 ± 11% (n = 18) in hypertrophied myocytes from rabbits 3 months after banding. The half-maximal activation concentration of (±)-isoproterenol was similar between control and hypertrophied myocytes. Forskolin (10 µM) induced a similar percentage of increase of ICa,L in control and hypertrophied myocytes, 109 ± 13% (n = 12) versus 120 ± 14% (n = 11) at 0 mV. The responsiveness of ICa,L to (±)-isoproterenol remained depressed in untreated hypertensive rabbits. (±)-Isoproterenol (1 µM) increased ICa,L at 0 mV by 64 ± 8% (n = 14) in myocytes isolated from rabbits 6 months after banding versus 111 ± 15% (n = 16) in age-matched controls. In captopril-treated rabbits, 1 µM (±)-isoproterenol increased ICa,L by 110 ± 11% (n = 17). We conclude that the maximal response of ICa,L to (±)-isoproterenol was severely depressed in hypertrophied myocytes. Chronic treatment of renovascular hypertension with captopril can restore normal responsiveness of ICa,L to (±)-isoproterenol in cardiac myocytes.


1 This work was supported in part by a grant from American Heart Association Southeastern Pennsylvania Affiliate (to X.X.).

2 Current address: Diagnostic Cardiovascular Consultants, Inc., 300 East Town St., Suite 1400, Columbus, OH 43215.


0022-3565/0/2921-0196$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.